New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 16 04:00PM ET
10.25
Dollar change
+0.14
Percentage change
1.42
%
Index- P/E- EPS (ttm)-0.20 Insider Own- Shs Outstand68.03M Perf Week-3.21%
Market Cap702.15M Forward P/E1863.44 EPS next Y0.01 Insider Trans- Shs Float- Perf Month-11.38%
Enterprise Value715.31M PEG- EPS next Q-0.10 Inst Own1.32% Short Float- Perf Quarter23.11%
Income-13.29M P/S2.19 EPS this Y18.75% Inst Trans-85.24% Short Ratio0.40 Perf Half Y0.28%
Sales320.29M P/B3.26 EPS next Y104.23% ROA-3.15% Short Interest0.00M Perf YTD1.83%
Book/sh3.15 P/C6.55 EPS next 5Y- ROE-6.33% 52W High12.61 -18.72% Perf Year22.74%
Cash/sh1.57 P/FCF257.20 EPS past 3/5Y- - ROIC-4.10% 52W Low6.65 54.12% Perf 3Y11.01%
Dividend Est.- EV/EBITDA37.67 Sales past 3/5Y14.32% 9.42% Gross Margin90.65% Volatility3.00% 3.15% Perf 5Y-
Dividend TTM- EV/Sales2.23 EPS Y/Y TTM-27.69% Oper. Margin1.96% ATR (14)0.50 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.00 Sales Y/Y TTM23.92% Profit Margin-4.15% RSI (14)47.62 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.76 EPS Q/Q-17.02% SMA20-3.18% Beta0.02 Target Price26.55
Payout- Debt/Eq0.56 Sales Q/Q42.73% SMA50-0.52% Rel Volume0.20 Prev Close10.10
Employees- LT Debt/Eq0.52 EarningsMay 08 BMO SMA20013.54% Avg Volume3.63K Price10.25
IPODec 23, 2020 Option/ShortNo / Yes EPS/Sales Surpr.-780.00% 16.77% Trades Volume735 Change1.42%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated Jefferies Buy $14
Jun-24-25 01:00AM
Jun-11-25 11:15AM
May-28-25 02:00AM
May-08-25 01:00AM
Apr-30-25 11:45AM
09:00AM Loading…
Apr-25-25 09:00AM
08:09AM
Apr-24-25 10:55AM
02:00AM
Apr-23-25 03:30AM
Apr-03-25 01:00AM
Apr-01-25 08:45AM
Mar-28-25 03:00AM
Mar-20-25 02:00AM
Mar-13-25 02:00AM
09:15AM Loading…
Mar-04-25 09:15AM
Feb-28-25 02:00AM
Feb-27-25 02:00AM
Feb-20-25 04:00PM
Feb-10-25 02:00AM
Feb-07-25 04:00PM
Jan-21-25 12:00PM
01:00AM
Dec-15-24 01:45PM
Dec-11-24 01:00AM
Nov-05-24 02:00AM
Oct-24-24 01:00AM
Oct-10-24 02:00AM
01:00AM
Sep-26-24 01:00AM
01:00AM Loading…
Sep-04-24 01:00AM
Aug-01-24 01:00AM
Jul-18-24 02:00AM
Jun-03-24 02:00AM
May-30-24 04:44PM
May-21-24 11:30AM
May-20-24 02:00AM
May-15-24 01:00AM
May-08-24 06:52AM
06:16AM
01:00AM
May-02-24 06:00AM
Apr-24-24 02:00AM
01:00AM
Apr-22-24 05:29AM
Apr-19-24 12:43PM
Apr-18-24 09:04AM
02:00AM
Apr-08-24 01:00AM
Apr-04-24 02:30AM
01:00AM
Apr-03-24 02:00AM
Mar-14-24 02:00AM
Feb-29-24 02:00AM
Feb-08-24 02:00AM
Jan-08-24 01:29AM
01:00AM
Dec-13-23 01:00AM
Nov-21-23 01:00AM
Nov-10-23 08:51AM
Nov-07-23 02:00AM
Nov-01-23 03:00AM
Oct-26-23 01:00AM
Oct-12-23 02:00AM
Sep-25-23 10:00AM
Aug-24-23 02:00AM
Aug-14-23 01:00AM
Aug-09-23 01:00AM
Aug-03-23 01:00AM
Jul-18-23 01:00AM
Jul-13-23 02:00AM
Jun-01-23 01:00AM
May-25-23 02:00AM
May-17-23 11:28AM
May-11-23 01:00AM
Apr-26-23 02:00AM
Apr-19-23 02:00AM
01:36AM
Apr-13-23 06:00AM
Apr-11-23 01:00AM
Apr-05-23 02:00AM
01:00AM
Mar-30-23 10:39AM
Mar-24-23 02:51PM
Mar-13-23 05:43AM
03:15AM
Mar-12-23 03:55PM
02:30PM
Feb-28-23 01:00AM
Feb-21-23 01:00AM
Feb-16-23 01:00AM
Dec-15-22 08:55AM
01:00AM
Dec-12-22 08:50AM
Dec-07-22 01:00AM
Dec-01-22 09:40AM
Nov-28-22 02:36AM
Nov-23-22 08:50AM
01:00AM
Nov-08-22 12:20PM
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST, Joenja, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.